Hi all!Welcome to the latest issue of your guide to AI, an editorialized newsletter covering key developments in AI research, industry, geopolitics and startups during July 2022. Before we kick off, a couple of news items from us :-)I discussed the state of AI in drug discovery with Chris Gibson (Recursion), Rich Law (Exscientia), and Najat Khan (Janssen) with MedCity News. You can watch the video here. If you’d like to make a slide contribution to the State of AI Report 2022, just reply to this email with your proposal. We’re back in-person with our non-profit RAAIS one-day summit on Friday 30th June 2023 in London. As usual, we’ll be hosting a top-tier group of large companies, startups, researchers and students all working on various aspects of AI. You can register your interest here.This edition was with Othmane Sebbouh and Nitarshan Rajkumar. Enjoy!
Share this post
🏄 Your guide to AI: August 2022
Share this post
Hi all!Welcome to the latest issue of your guide to AI, an editorialized newsletter covering key developments in AI research, industry, geopolitics and startups during July 2022. Before we kick off, a couple of news items from us :-)I discussed the state of AI in drug discovery with Chris Gibson (Recursion), Rich Law (Exscientia), and Najat Khan (Janssen) with MedCity News. You can watch the video here. If you’d like to make a slide contribution to the State of AI Report 2022, just reply to this email with your proposal. We’re back in-person with our non-profit RAAIS one-day summit on Friday 30th June 2023 in London. As usual, we’ll be hosting a top-tier group of large companies, startups, researchers and students all working on various aspects of AI. You can register your interest here.This edition was with Othmane Sebbouh and Nitarshan Rajkumar. Enjoy!